Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/213229
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes

AutorLamas, Cristina; Navarro-Villarán, Elena CSIC ORCID CVN; Casterás, Anna; Portillo, Paloma; Alcázar, Victoria; Calatayud, María; Álvarez-Escolá, Cristina; Sastre, Julia; Boix, Evangelina; Forga, Luis; Vicente, Almudena; Oriola, Josep; Mesa, Jordi; Valdés, Nuria
Palabras claveMultiple endocrine neoplasia type 1
MEN1 gene
Primary hyperparathyroidism
Parathyroidectomy
Hypoparathyroidism
Fecha de publicación2019
EditorEuropean Society of Endocrinology
Society for Endocrinology
CitaciónEndocrine Connections 8(10): 1416-1424 (2019)
ResumenPrimary hyperparathyroidism is the most frequent manifestation of multiple endocrine neoplasia type 1 (MEN1) syndrome. Bone and renal complications are common. Surgery is the treatment of choice, but the best timing for surgery is controversial and predictors of persistence and recurrence are not well known. Our study describes the clinical characteristics and the surgical outcomes, after surgery and in the long term, of the patients with MEN1 and primary hyperparathyroidism included in the Spanish Registry of Multiple Endocrine Neoplasia, Pheochromocytomas and Paragangliomas (REGMEN). Eighty-nine patients (49 men and 40 women, 34.2 ± 13 years old) were included. Sixty-four out of the 89 underwent surgery: a total parathyroidectomy was done in 13 patients, a subtotal parathyroidectomy in 34 and a less than subtotal parathyroidectomy in 15. Remission rates were higher after a total or a subtotal parathyroidectomy than after a less than subtotal (3/4 and 20/22 vs 7/12, P < 0.05), without significant differences in permanent hypoparathyroidism (1/5, 9/23 and 0/11, N.S.). After a median follow-up of 111 months, 20 of the 41 operated patients with long-term follow-up had persistent or recurrent hyperparathyroidism. We did not find differences in disease-free survival rates between different techniques, patients with or without permanent hypoparathyroidism and patients with different mutated exons, but a second surgery was more frequent after a less than subtotal parathyroidectomy.
Descripción© 2019 The authors.
Versión del editorhttp://dx.doi.org/10.1530/EC-19-0321
URIhttp://hdl.handle.net/10261/213229
DOI10.1530/EC-19-0321
ISSN2049-3614
E-ISSN2049-3614
Aparece en las colecciones: (IBIS) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
MEN1_associated_Lamas_Art2019.pdf734,05 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

6
checked on 11-mar-2024

SCOPUSTM   
Citations

16
checked on 22-mar-2024

WEB OF SCIENCETM
Citations

12
checked on 27-feb-2024

Page view(s)

96
checked on 28-mar-2024

Download(s)

79
checked on 28-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons